EMBC
Embecta Corp.Healthcare · $337M market cap
Verdict
Share price
$5.65
close of Oct 3, 2026
Fair value
$16.03
Sticker Price
Payback Price
$6.41
buy price
EMBC is On Sale: at $5.65 it trades 12% below its buy price (Payback Price) of $6.41 and 65% below its fair value of $16.03. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow EMBC
Get notified when it reaches its buy price of $6.41. Free.
Create a free accountSuperinvestors
1 of the investors we track holds EMBC. In Q2 2026, 1 added and 1 sold out. Who we track
Insider activity
Since Aug 9, 2026: 4 open-market purchases worth $558K, 1 sale worth $37K and 1 other filing (stock awards, tax withholding and similar). Why purchases matter
Purchases
HOMBACH ROBERT J.
director · 2026-08-12
Bought
$224K
Mann Jeffrey Z
Pres, Pharm Svc&Prod Mgmt, CLO · 2026-08-12
Bought
$100K
Elguicze Jacob
SVP and CFO · 2026-08-12
Bought
$93K
Kurdikar Devdatt
President and CEO · 2026-08-12
Bought
$141K
Sales
Other filings
About Embecta Corp.
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta…
Medical - Instruments & Supplies
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works